CABLIVI Trademark

Trademark Overview


On Wednesday, August 10, 2016, a trademark application was filed for CABLIVI with the United States Patent and Trademark Office. The USPTO has given the CABLIVI trademark a serial number of 87133457. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Friday, January 19, 2024. This trademark is owned by Ablynx N.V.. The CABLIVI trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the prevention and treatment of auto immune disorders, disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the genitourinary system, for the treatment of inflammatory disorders, skin disorders and for use in hematology [ and in tissue and organ transplantation; ] pharmaceutical drugs, namely, prescription medicines, for administration by injection or infusion, for the prevention and treatment of auto immune disorders, disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the genitourinary system, for the treatment of inflammatory disorders, skin disorders and for use in hematology [ and in tissue and organ transplantation ]
cablivi

General Information


Serial Number87133457
Word MarkCABLIVI
Filing DateWednesday, August 10, 2016
Status701 - SECTION 8 - ACCEPTED
Status DateFriday, January 19, 2024
Registration Number5283923
Registration DateTuesday, September 12, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2017

Trademark Statements


Goods and Servicespharmaceutical preparations for the prevention and treatment of auto immune disorders, disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the genitourinary system, for the treatment of inflammatory disorders, skin disorders and for use in hematology [ and in tissue and organ transplantation; ] pharmaceutical drugs, namely, prescription medicines, for administration by injection or infusion, for the prevention and treatment of auto immune disorders, disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the genitourinary system, for the treatment of inflammatory disorders, skin disorders and for use in hematology [ and in tissue and organ transplantation ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 15, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAblynx N.V.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressZwijnaarde BE-9052
BE

Party NameAblynx N.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE-9052 Zwijnaarde
BE

Party NameAblynx N.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE-9052 Zwijnaarde
BE

Trademark Events


Event DateEvent Description
Wednesday, September 28, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, August 13, 2016NEW APPLICATION ENTERED
Monday, August 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 28, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 6, 2016ASSIGNED TO LIE
Thursday, October 20, 2016ASSIGNED TO LIE
Monday, October 24, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 24, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 22, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 21, 2016ASSIGNED TO EXAMINER
Tuesday, November 22, 2016NON-FINAL ACTION WRITTEN
Tuesday, November 22, 2016NON-FINAL ACTION E-MAILED
Wednesday, May 17, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 17, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 17, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 18, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 23, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 7, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 27, 2017PUBLISHED FOR OPPOSITION
Tuesday, June 27, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, October 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 12, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, November 6, 2023TEAS SECTION 8 RECEIVED
Friday, January 19, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 6, 2024TEAS SECTION 7 REQUEST RECEIVED
Friday, January 19, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, January 19, 2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED